Added to YB: 2024-03-28
Pitch date: 2024-03-28
ACHV:US [bullish]
Achieve Life Sciences, Inc.
-3.23%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom.
Market Cap
$149.2M
Pitch Price
$4.64
Price Target
N/A
Dividend
N/A
EV/EBITDA
-2.09
P/E
-2.00
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
Achieve Life Sciences, Inc. ACHV:US
A summary for this pitch has not been created yet.
Read full article (0 min)